Biopharmaceutical Fermentation Systems Industry Report 2024 - Upstream Products Segment is Forecast to Reach US$6.5 Billion by 2030 with a CAGR of a 3.7%
December 09, 2024 09:32 ET
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Fermentation Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...
$55.7 Billion Biopharmaceutical Fermentation Systems Market Opportunities and Strategies to 2033: Development of New Bioreactors to Enhance Single-Use Upstream Operations, New Technology Developments
November 22, 2024 05:54 ET
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Fermentation Systems Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. The...
Biosimilars Market Industry Report 2024 - Rising Demand for Biosimilars as a Cost-effective Alternative has Promoted the Need for Increased In-house Development and Outsourcing Operations
November 08, 2024 04:37 ET
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution...
Cell-Free Protein Expression Market Outlook to 2029 with Profiles on Key Players - Thermo Fisher Scientific, Takara Bio USA, Merck, New England Biolabs, Jena Bioscience & More - A Projected $432M Landscape
October 10, 2024 06:18 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Cell-free Protein Expression Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Dyadic Expands Global Presence with Participation in Key Industry Events
October 09, 2024 08:00 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient manufacturing of...
Protein Therapeutics Strategic Research Report 2023-2030: Rising Demand for Cost-Effective and Scalable Therapeutics Throws Spotlight on Market Adoption
October 08, 2024 04:37 ET
|
Research and Markets
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Protein Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Protein...
Protein Expression Market Industry Trends and Global Forecasts to 2035: Since 2023, Over 6,500 Patents Related to Protein Expression have been Granted
September 27, 2024 11:55 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Protein Expression Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Protein Expression System, Protein Expression-related...
Europe Protein Expression Market Research 2024: Increasing Demand for Protein Biologics Creating the Need for Protein Expression - Forecasts to 2033
August 22, 2024 10:09 ET
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Europe Protein Expression Market: Focus on Application, End User, Product, Expression System, and Country - Analysis and Forecast, 2023-2033" report...
Global Biologics Contract Development and Manufacturing Organizations Market Report 2024-2029: End-to-end mRNA Services & Expanding Drug Capabilities to Support Anti-obesity Drugs Fuels Opportunities
July 31, 2024 09:41 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024-2029" report has been added to ResearchAndMarkets.com's...
Europe Biologics CDMO Market Research 2023-2032: Companies that Skillfully Navigate Regulatory Complexities and Adopt Technological Innovations are Well-Positioned for Significant Success
July 01, 2024 05:09 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Europe Biologics CDMO Market: Focus on Cell Type, Molecule Type, and Country - Analysis and Forecast, 2023-2032" report has been added to ...